These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26861092)

  • 41. [Criteria for an optimal isotope in gynecologic radiotherapy].
    Walstam R
    Strahlentherapie; 1975 Sep; 150(3):258-60. PubMed ID: 1209667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [HDR or LDR in gynecological brachytherapy?].
    Prager W
    Strahlenther Onkol; 1994 Jun; 170(6):368. PubMed ID: 8023249
    [No Abstract]   [Full Text] [Related]  

  • 43. Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectives.
    Magné N; Haie-Meder C
    Lancet Oncol; 2007 Aug; 8(8):725-9. PubMed ID: 17679082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current methods in brachytherapy of female genital malignancies].
    Kanaev SV; Turkevich VG; Baranov SB
    Vopr Onkol; 1997; 43(1):47-53. PubMed ID: 9133086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Howard Kelly establishes gynecologic brachytherapy in the United States.
    Aronowitz JN; Robison RF
    Brachytherapy; 2010; 9(2):178-84. PubMed ID: 20022564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
    Lee LJ; Damato AL; Viswanathan AN
    Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
    Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gynecologic brachytherapy--from low-dose-rate to high-tech].
    Herrmann T; Christen N; Alheit HD
    Strahlenther Onkol; 1993 Mar; 169(3):141-51. PubMed ID: 8465248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resource utilization. High dose rate versus low dose rate brachytherapy for gynecologic cancer.
    Bastin K; Buchler D; Stitt J; Shanahan T; Pola Y; Paliwal B; Kinsella T
    Am J Clin Oncol; 1993 Jun; 16(3):256-63. PubMed ID: 8338060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The radiobiology of gynecologic HDR and LDR afterloading technics].
    Bauer M; Schulz-Wendtland R
    Rontgenblatter; 1989 Jan; 42(1):54-6. PubMed ID: 2645638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Intracavitary brachytherapy with long and short-term afterloading technic in gynecology].
    Bauer M
    Gynakologe; 1987 Dec; 20(4):228-36. PubMed ID: 3325373
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of recurrent pelvic and selected primary gynecologic malignancies with 241Am.
    Chung JY; Roberts K; Peschel RE; Nath R; Pourang R; Kacinski B; Wilson L
    Radiat Oncol Investig; 1997; 5(5):227-34. PubMed ID: 9372545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helical tomotherapy delivery of an IMRT boost in lieu of interstitial brachytherapy in the setting of gynecologic malignancy: feasibility and dosimetric comparison.
    Gielda BT; Shah AP; Marsh JC; Smart JP; Bernard D; Rotmensch J; Griem KL
    Med Dosim; 2011; 36(2):206-12. PubMed ID: 20537887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical experience with short-term afterloading therapy in comparison with conventional brachytherapy in the treatment of gynecologic tumors].
    Glaser FH; Grimm D; Haensgen G; Rauh G; Schuchardt V
    Strahlentherapie; 1985 Aug; 161(8):459-75. PubMed ID: 3927526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [GEC-ESTRO Annual Brachytherapy Meeting, Linz 9-11 May 1994].
    Hammer J; Gerbaulet A
    Zentralbl Gynakol; 1994; 116(10):591-4. PubMed ID: 7810249
    [No Abstract]   [Full Text] [Related]  

  • 56. Brachytherapy-a dose of pragmatism needed.
    The Lancet Oncology
    Lancet Oncol; 2021 Jun; 22(6):737. PubMed ID: 34087119
    [No Abstract]   [Full Text] [Related]  

  • 57. The ICRU 38, a need for a new edition.
    de Almeida CE; Almond PR
    Radiother Oncol; 1997 Mar; 42(3):315-6. PubMed ID: 9155085
    [No Abstract]   [Full Text] [Related]  

  • 58. Development of a Multi-Institutional Simulation-Based Gynecologic Brachytherapy Curriculum.
    Singer L; Damast S; Lin L; Taunk N; Lee LJ; Albuquerque K; Chino J; Petereit D; Joyner M; Fields E
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1175-1176. PubMed ID: 31327414
    [No Abstract]   [Full Text] [Related]  

  • 59. Interdisciplinary support of the gynecologic cancer patient.
    Tortora JM; MacFarlane PH; Berman B
    JOGN Nurs; 1979; 8(6):348-9. PubMed ID: 260786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limiting Access to Abortion Will Potentially Harm Patients With Gynecologic Cancers.
    Chino J; Yashar C; Klopp A; Viswanathan A
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):396-398. PubMed ID: 35963471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.